AstroNova (ALOT) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
20 Jan, 2026Executive summary
Q2 FY2025 revenue increased 14.1% year-over-year to $40.5 million, driven by strong Test & Measurement growth and the MTEX acquisition, with domestic revenue up 18.2% and international up 8.8%.
The Product Identification segment benefited from the MTEX acquisition, with Q2 revenue up over 5% year-over-year and non-GAAP operating profit up 26.5% excluding MTEX.
Net loss for Q2 was $0.3 million, a significant improvement from a $1.6 million loss in the prior year, impacted by MTEX acquisition costs and CFO transition charges.
Strong demand in aerospace, especially for printers and MRO services, was fueled by global aviation recovery and new military contracts.
MTEX integration is ongoing, with initial Q2 revenue under $0.8 million and an operating loss of $1.4 million; full integration is expected by the end of FY2025.
Financial highlights
Q2 gross profit was $14.3 million, up 47.5% year-over-year, with gross margin improving to 35.3% from 27.3%; non-GAAP gross margin was 35.6%.
Q2 operating income was $1.1 million, compared to a $1.2 million loss in the prior year; non-GAAP operating income was $2.2 million.
Adjusted EBITDA for Q2 was $3.9 million, up 5.3% year-over-year.
Q2 EPS was $(0.04) basic and diluted; non-GAAP diluted EPS was $0.08; six-month EPS was $0.12 basic and $0.11 diluted.
Bookings in Q2 were $35.8 million, up from $30.1 million last year; backlog at quarter-end was $29.9 million.
Outlook and guidance
Full-year FY2025 guidance reaffirmed for mid-single-digit percent organic revenue growth, with margin guidance lowered to 9%-10% due to MTEX integration delays; target margin of 13%-14% for FY2026.
MTEX expected to contribute $8–10 million in revenue for FY2025, with profitability improvements anticipated as integration completes and backlog shipments in Q3 and Q4.
Long-term goal to improve Adjusted EBITDA margin by 100 basis points annually beyond FY2026.
Focus for the remainder of FY2025 is on inventory reduction and debt repayment.
Latest events from AstroNova
- Recurring revenue, acquisitions, and innovation drive growth and margin expansion.ALOT
Sidoti Micro-Cap Virtual Conference2 Feb 2026 - Q1 revenue down 7%, net income up, and MTEX NS acquisition boosts future growth.ALOT
Q1 20251 Feb 2026 - Accelerating growth through innovation, acquisitions, and operational excellence.ALOT
2024 Southwest IDEAS Conference13 Jan 2026 - Revenue up 7.7% but net income and margins fell sharply amid MTEX integration challenges.ALOT
Q3 202511 Jan 2026 - Q3 FY26 revenue up 8.5% sequentially, margins and cash flow improved, outlook reaffirmed.ALOT
Q3 202612 Dec 2025 - Board recommends its director slate, annual say-on-pay, and auditor ratification amid proxy contest.ALOT
Proxy Filing1 Dec 2025 - Board recommends its nominees and strategic direction amid proxy contest and operational changes.ALOT
Proxy Filing1 Dec 2025 - Six director nominees proposed, board rejects dissident slate to protect strategic direction.ALOT
Proxy Filing1 Dec 2025 - Annual meeting features director elections, executive pay votes, and auditor ratification.ALOT
Proxy Filing1 Dec 2025